We are live on ! Find out more
Arrowstreet Capital

Arrowstreet Capital Portfolio holdings

AUM $185B
1-Year Est. Return 39.58%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
+39.58%
3 Year Est. Return
+145.48%
5 Year Est. Return
+192.07%
10 Year Est. Return
+749.75%
AUM
$33B
AUM Growth
+$5.76B
Cap. Flow
+$4.83B
Cap. Flow %
14.64%
Top 10 Hldgs %
18%
Holding
1,503
New
268
Increased
383
Reduced
361
Closed
471

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$470M
2
AMZN icon
Amazon
AMZN
+$436M
3
GE icon
GE Aerospace
GE
+$381M
4
RY icon
Royal Bank of Canada
RY
+$368M
5
CNI icon
Canadian National Railway
CNI
+$354M

Top Sells

Rank Stock Value
1
T icon
AT&T
T
+$365M
2
CSCO icon
Cisco
CSCO
+$266M
3
GSK icon
GSK
GSK
+$248M
4
CVS icon
CVS Health
CVS
+$187M
5
BTI icon
British American Tobacco
BTI
+$168M

Sector Composition

Rank Sector Weight
1 Technology 19.43%
2 Financials 19.11%
3 Healthcare 13.53%
4 Consumer Staples 11.65%
5 Industrials 10.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TDW icon
1001
Tidewater
TDW
$3.73B
$188K ﹤0.01%
+8,096
New +$218K
GTS
1002
DELISTED
Triple-S Management Corporation
GTS
$187K ﹤0.01%
+11,636
New +$191K
FNWB icon
1003
First Northwest Bancorp
FNWB
$109M
$183K ﹤0.01%
11,633
-1,400
-11% -$22.8K
AVDL
1004
DELISTED
Avadel Pharmaceuticals
AVDL
$181K ﹤0.01%
+16,400
New +$165K
SHOS
1005
DELISTED
Sears Hometown and Outlet Stores, Inc.
SHOS
$178K ﹤0.01%
66,051
RCKY icon
1006
Rocky Brands
RCKY
$366M
$176K ﹤0.01%
+13,100
New +$176K
ATRS
1007
DELISTED
Antares Pharma, Inc.
ATRS
$174K ﹤0.01%
+54,000
New +$153K
MNR
1008
DELISTED
Monmouth Real Estate Investment Corp
MNR
$173K ﹤0.01%
+11,500
New +$170K
TRIB
1009
Trinity Biotech
TRIB
$7.83M
$172K ﹤0.01%
191
-46
-19% -$39.1K
AXTI icon
1010
AXT Inc
AXTI
$3.95B
$171K ﹤0.01%
27,000
-6,700
-20% -$43.8K
USDP
1011
DELISTED
USD PARTNERS LP
USDP
$165K ﹤0.01%
+14,700
New +$191K
FNJN
1012
DELISTED
Finjan Holdings, Inc.
FNJN
$162K ﹤0.01%
+49,264
New +$128K
MDXG icon
1013
MiMedx Group
MDXG
$602M
$157K ﹤0.01%
+10,500
New +$140K
SCM icon
1014
Stellus Capital Investment Corp
SCM
$217M
$155K ﹤0.01%
+11,300
New +$158K
SITC icon
1015
SITE Centers
SITC
$225M
$149K ﹤0.01%
+12,728
New +$166K
CYS
1016
DELISTED
CYS Investments Inc.
CYS
$146K ﹤0.01%
17,400
-658,091
-97% -$5.53M
CDXS icon
1017
Codexis
CDXS
$151M
$145K ﹤0.01%
26,639
-10,300
-28% -$47.4K
FG
1018
DELISTED
FGL Holdings Ordinary Shares
FG
$145K ﹤0.01%
+12,931
New +$137K
PCTI
1019
DELISTED
PCTEL, Inc. Common Stock
PCTI
$143K ﹤0.01%
+20,247
New +$142K
MTG icon
1020
MGIC Investment
MTG
$6.16B
$132K ﹤0.01%
+11,800
New +$127K
HALO icon
1021
Halozyme
HALO
$9.79B
$131K ﹤0.01%
+10,200
New +$136K
PZE
1022
DELISTED
Petrobras Argentina S A
PZE
$126K ﹤0.01%
10,484
-1,956
-16% -$23.8K
DAKT icon
1023
Daktronics
DAKT
$955M
$123K ﹤0.01%
+12,760
New +$120K
IMGN
1024
DELISTED
Immunogen Inc
IMGN
$102K ﹤0.01%
+14,400
New +$65.9K
GEN
1025
DELISTED
Genesis Healthcare, Inc.
GEN
$98K ﹤0.01%
56,304

Similar funds

Arrowstreet Capital's Q2 2017 Portfolio in Review

As of Q2 2017, Arrowstreet Capital held 1,503 positions worth $33B, up 21% from $27.3B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Arrowstreet Capital deployed $4.83B of net new capital in Q2 2017, opening 268 new positions and adding to 383 existing holdings. Its largest new stake was MetLife: 1,568,893 shares worth $76.8M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Cisco, an estimated $266M trimmed.

  • Arrowstreet Capital's largest Q2 2017 buy was MetLife: 1,568,893 shares worth $76.8M.
  • Arrowstreet Capital added most to Apple in Q2 2017, an estimated $470M increase.
  • Arrowstreet Capital's biggest Q2 2017 reduction was Cisco, cutting an estimated $266M.
  • Arrowstreet Capital fully exited AT&T in Q2 2017, selling an estimated $365M.
  • Arrowstreet Capital's ten largest holdings make up 18% of its $33B portfolio in Q2 2017.
  • Arrowstreet Capital opened 268 new positions and closed 471 in Q2 2017.
  • Arrowstreet Capital's portfolio value rose 21% quarter-over-quarter to $33B.

Based on Arrowstreet Capital's 13F filing for Q2 2017, filed 15 Aug 2017.